Our mission
At Cereus Biosciences, our mission is to revolutionize cancer treatment and make the world cancer-free by developing universal, cost-effective vaccines that trigger targeted immune responses. Leveraging advanced computational genomics and partnerships with leading research institutions, we aim to create accessible, off-the-shelf cancer vaccines to address the urgent needs of patients worldwide.
Our work
Cereus Biosciences is at the forefront of the second immunotherapy revolution. We focus on identifying shared neoantigens to develop universal cancer vaccines, starting with pancreatic cancer. Our innovative platform integrates cutting-edge bioinformatics and immunology, validated in collaboration with the Institut Curie. Our goal is to bring effective, readily available cancer vaccines to clinical trials, ultimately improving survival rates and quality of life for patients.
